169 related articles for article (PubMed ID: 37791986)
1. The crossroad of nanovesicles and oral delivery of insulin.
Fadaei MR; Mohammadi M; Fadaei MS; Jaafari MR
Expert Opin Drug Deliv; 2023; 20(10):1387-1413. PubMed ID: 37791986
[TBL] [Abstract][Full Text] [Related]
2. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
Wong CY; Al-Salami H; Dass CR
Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
[TBL] [Abstract][Full Text] [Related]
3. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.
Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S
Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598
[TBL] [Abstract][Full Text] [Related]
4. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines.
Aburahma MH
Drug Deliv; 2016 Jul; 23(6):1847-67. PubMed ID: 25390191
[TBL] [Abstract][Full Text] [Related]
5. Unlocking the Potential of Bilosomes and Modified Bilosomes: a Comprehensive Journey into Advanced Drug Delivery Trends.
Nayak D; Rathnanand M; Tippavajhala VK
AAPS PharmSciTech; 2023 Nov; 24(8):238. PubMed ID: 37989979
[TBL] [Abstract][Full Text] [Related]
6. Addressing the Superior Drug Delivery Performance of Bilosomes─A Microscopy and Fluorescence Study.
Mondal D; Mandal RP; De S
ACS Appl Bio Mater; 2022 Aug; 5(8):3896-3911. PubMed ID: 35924346
[TBL] [Abstract][Full Text] [Related]
7. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate.
Elnaggar YSR; Omran S; Hazzah HA; Abdallah OY
Int J Pharm; 2019 Jun; 564():410-425. PubMed ID: 31029657
[TBL] [Abstract][Full Text] [Related]
8. Bilosomes in the context of oral immunization: development, challenges and opportunities.
Shukla A; Mishra V; Kesharwani P
Drug Discov Today; 2016 Jun; 21(6):888-99. PubMed ID: 27038539
[TBL] [Abstract][Full Text] [Related]
9. Nanovesicles-Mediated Drug Delivery for Oral Bioavailability Enhancement.
Ren Y; Nie L; Zhu S; Zhang X
Int J Nanomedicine; 2022; 17():4861-4877. PubMed ID: 36262189
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in nanoparticles for the treatment of diabetes.
Sharma DK; Pattnaik G; Behera A
J Drug Target; 2023 Dec; 31(9):908-919. PubMed ID: 37725445
[TBL] [Abstract][Full Text] [Related]
11. Biotinylated liposomes as potential carriers for the oral delivery of insulin.
Zhang X; Qi J; Lu Y; He W; Li X; Wu W
Nanomedicine; 2014 Jan; 10(1):167-76. PubMed ID: 23891617
[TBL] [Abstract][Full Text] [Related]
12. Potential of Liposomes for Enhancement of Oral Drug Absorption.
Daeihamed M; Dadashzadeh S; Haeri A; Akhlaghi MF
Curr Drug Deliv; 2017; 14(2):289-303. PubMed ID: 26768542
[TBL] [Abstract][Full Text] [Related]
13. Enhancing oral bioavailability of insulin through bilosomes: Implication of charge and chain length on apical sodium-dependent bile acid transporter (ASBT) uptake.
Nallamothu B; Kuche K; Ghadi R; Chaudhari D; Jain S
Int J Biol Macromol; 2023 Dec; 252():126565. PubMed ID: 37640185
[TBL] [Abstract][Full Text] [Related]
14. Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides.
Ahmad J; Singhal M; Amin S; Rizwanullah M; Akhter S; Kamal MA; Haider N; Midoux P; Pichon C
Curr Pharm Des; 2017; 23(11):1575-1588. PubMed ID: 28120725
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W
Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880
[TBL] [Abstract][Full Text] [Related]
16. Bilosomes: A Novel Approach to Meet the Challenges in Oral Immunization.
Chauhan MK; Sahoo PK; Rawat AS; Singh A; Bamrara A; Sharma D
Recent Pat Drug Deliv Formul; 2015; 9(3):201-12. PubMed ID: 26072957
[TBL] [Abstract][Full Text] [Related]
17. Facilitated permeation of insulin across TR146 cells by cholic acid derivatives-modified elastic bilosomes.
Bashyal S; Seo JE; Keum T; Noh G; Choi YW; Lee S
Int J Nanomedicine; 2018; 13():5173-5186. PubMed ID: 30233179
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of niosome-loaded insulin in diabetic rats.
Pardakhty A; Moazeni E; Varshosaz J; Hajhashemi V; Rouholamini Najafabadi A
Daru; 2011; 19(6):404-11. PubMed ID: 23008685
[TBL] [Abstract][Full Text] [Related]
19. Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.
Ahad A; Raish M; Ahmad A; Al-Jenoobi FI; Al-Mohizea AM
Eur J Pharm Sci; 2018 Jan; 111():409-417. PubMed ID: 29030177
[TBL] [Abstract][Full Text] [Related]
20. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.
Hu S; Niu M; Hu F; Lu Y; Qi J; Yin Z; Wu W
Int J Pharm; 2013 Jan; 441(1-2):693-700. PubMed ID: 23089580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
